Metoprolol Fumarate

CHEMBL3989566 Phase 4 Onaylandı Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
650.8 g/mol
LogP
Phase
4

This is the fumarate salt form of metoprolol; see metoprolol for full prescribing information.

Moleküler Ağırlık

650,8000 g/mol

TPSA

176,00 Ų

Terapötik Alanlar

Etki Mekanizması

Selective beta-1 adrenergic receptor blocker.

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Mekanizma

Selective beta-1 adrenergic receptor blocker.

2D Yapı

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

COCCc1ccc(OCC(O)CNC(C)C)cc1.COCCc1ccc(OCC(O)CNC(C)C)cc1.O=C(O)/C=C/C(=O)O

InChI

InChI=1S/2C15H25NO3.C4H4O4/c2*1-12(2)16-10-14(17)11-19-15-6-4-13(5-7-15)8-9-18-3;5-3(6)1-2-4(7)8/h2*4-7,12,14,16-17H,8-11H2,1-3H3;1-2H,(H,5,6)(H,7,8)/b;;2-1+

Molecular Formula

C34H54N2O10

HBD / HBA

6 / 12

Döndürülebilir Bağlar

20

Ağır Atomlar

46

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Sıkça Sorulan Sorular

This is the fumarate salt form of metoprolol; see metoprolol for full prescribing information.

Selective beta-1 adrenergic receptor blocker.

Yes, Metoprolol Fumarate is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL3989566. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 6440651. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

Tıbbi Sorumluluk Reddi

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.